Bioactive secondary metabolites from the deep-sea derived fungus Aspergillus sp. SCSIO 41029
- PMID: 33106626
- DOI: 10.1038/s41429-020-00378-y
Bioactive secondary metabolites from the deep-sea derived fungus Aspergillus sp. SCSIO 41029
Abstract
Two new compounds classified as one new lumazine peptide, penilumamide K (1) and one new sesquiterpene (2), were obtained from the deep-sea derived fungus Aspergillus sp. SCSIO 41029, together with eleven known compounds (3-13). The structures of 1-13 including absolute configurations were determined by detailed NMR spectroscopy, HR-ESI-MS, chemical derivatization, and optical rotation data. Among them, compound 1 represents the first lumazine peptide reported from deep-sea derived fungus. The bioactive assay exhibited that compounds 1, 3, 4, 5, 7 and 10 had significant potency against α-glucosidase with IC50 values ranging from 18.61 to 109.06 μΜ. In addition, compounds 4 and 9 showed strong antibacterial activity against Staphylococcus aureus with MIC values of 0.78 and 6.25 μg ml-1, respectively.
References
-
- Rateb ME, Ebel R. Secondary metabolites of fungi from marine habitats. Nat Prod Rep. 2011;28:290–344. - DOI
-
- Orlova TI, Bulgakova VG, Polin AN. Secondary metabolites from marine microorganisms. II. Marine fungi and their habitats. Antibiot Khimioter. 2016;61:52–63. - PubMed
-
- Carroll AR, et al. Marine natural products. Nat Prod Rep. 2020;37:175–223. - DOI
-
- Skropeta D, Wei L. Recent advances in deep-sea natural products. Nat Prod Rep. 2014;31:999–1025. - DOI
-
- Han WR, et al. Protein tyrosine phosphatase 1B (PTP1B) inhibitors from the deep-sea fungus Penicillium chrysogenum SCSIO 07007. Bioorg Chem. 2020;96:103646. https://doi.org/10.1016/j.bioorg.2020.103646 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical